CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368

Search Health Library

Guillain-Barré Syndrome

(Acute Inflammatory Demyelinating Polyradiculoneuropathy; Acute Inflammatory Demyelinating Polyneuropathy; Acute Idiopathic Polyneuritis; Acute Inflammatory Polyneuropathy; Acute Autoimmune Neuropathy; Idiopathic Polyneuritis; AIDP)

Pronounced: gee-yan bah-ray sin-droam

Definition

Guillain-Barré syndrome is a rare condition that causes the immune system to attack the nerves outside of the brain and spinal cord. It is characterized by numbness, tingling, weakness, or paralysis in the legs, arms, breathing muscles, and face. It can affect all ages.

Nervous System

CNS and PNS
Copyright © Nucleus Medical Media, Inc.

Causes    TOP

The exact cause of Guillain-Barré syndrome is unknown. However in about 70% of people, a recent infection or surgery triggers an autoimmune response. This autoimmune response attacks the peripheral nerves, leading to weakness and a loss of sensation.

Risk Factors    TOP

Guillain-Barré syndrome is more common in men, and in the those aged 15-35 years and 60-75 years old. Other factors that increase your chance of Guillain-Barré syndrome may include:

  • Recent gastrointestinal or respiratory infection by viruses or bacteria
  • Recent vaccination—especially influenza and meningococcal
    • The swine flu vaccine given from 1976-1977 was linked to excess cases of Guillain-Barré syndrome. (Since then, influenza virus vaccines have been associated with only a marginally increased risk of Guillain-Barré syndrome.)
  • Recent surgery
  • History of lymphoma, systemic lupus erythematosus, or HIV infection

Symptoms    TOP

The first symptoms of Guillain-Barré syndrome include:

  • Pain—the lower back pain is the most common complaint
  • Progressive muscle weakness on both sides of the legs, arms, and face
  • Prickly, tingling sensations, usually in the feet or hands
  • Loss of normal reflexes

Symptoms may develop over a period of hours, days, or weeks. They will vary in severity from minimal to total paralysis including respiratory weakness. The symptoms grow progressively worse. Most people experience the greatest weakness during the second or third week.

Related complications include:

  • Facial weakness
  • Blood pressure instability
  • Heart rate changes
  • Sweating abnormalities
  • Heart arrhythmias
  • Urinary/gastrointestinal dysfunction
  • Breathing difficulty
  • Death

Most people fully recover, but others may have residual symptoms, or permanent or disabling problems.

Diagnosis    TOP

Your doctor will ask about your symptoms and medical history. A physical will be done.

Tests may include:

Treatment    TOP

Treatment aims to reduce the body’s autoimmune response and decrease complications that result from immobility. Hospitalization is important because symptoms may rapidly become more severe, including respiratory failure, heart arrhythmias, and blood pressure instability.

Common treatments include:

Plasmapheresis

During plasmapheresis, blood is removed from your body and passed through a machine that separates blood cells. The separated cells are then returned to your body with new plasma. This procedure may help shorten the course and severity of Guillain-Barré syndrome.

High-dose Immunoglobulin Therapy

Intravenous infusion with immunoglobulin (IVIg) may help reduce the severity of a Guillain-Barré attack. Immunoglobulins are proteins that are naturally produced by the body’s immune system.

Mechanical Ventilation    TOP

In some cases, muscles necessary for breathing become paralyzed. This is treated with immediate emergency support from a mechanical ventilator.

Medications    TOP

Your doctor may advise

  • Over-the-counter or prescription pain relievers
  • Antiseizure medications

Prevention    TOP

There are no current guidelines to prevent Guillain-Barré syndrome.

RESOURCES:

Guillain-Barré Syndrome Foundation International
http://www.gbs-cidp.org/
National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov/

CANADIAN RESOURCES:

Canadian Institute for Health Information
http://www.cihi.ca

References:

Amyotrophic lateral sclerosis. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated July 25, 2016. Accessed September 23, 2016.
Guillain-Barre syndrome. EBSCO DynaMed Plus website. Available at: Available at: http://www.dynamed.... Updated September 10, 2016. Accessed September 23, 2016.
Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre: an update. J Clinical Neuroscience. 2009;16(6):733-741.
Last reviewed March 2017 by EBSCO Medical Review BoardRimas Lukas, MD
Last Updated: 5/7/2014

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Health Library: Editorial Policy | Privacy Policy | Terms and Conditions | Support
36000 Darnall Loop Fort Hood, Texas 76544-4752 | Phone: (254) 288-8000